ABSTRACT
Infliximab is a well-known treatment for inflammatory bowel diseases [IBDs] and psoriasis. Paradoxically, there have been numerous reports of new-onset psoriasis following tumor necrosis factor-??antagonist therapy in patients with IBD. Here, we report a case with Crohn's disease who developed Infliximab-induced plaque-type psoriasis 4 months after initiation of treatment with Infliximab
ABSTRACT
Tinea capitis is a common superficial fungal infection of the scalp, with a propensity for attacking hair shafts and follicles. The disease is considered to be a form of dermatophytosis caused predominantly by Trichophyton or Microsporum species. It is observed generally but not exclusively in prepubertal children. Clinical presentations are variable, but the major clinical patterns are the gray patch, the seborrheic-like, the "black dot", the favic type, and the inflammatory tinea capitis with kerion and tiny pustules in the scalp. Diagnosis is aided by wood's light and confirmed by microscopic examination and culture. Treatment of tinea capitis requires the use of oral antifungal agents since topical treatment usually is ineffective. This review summarizes all data mentioned in the literature about tinea capitis with some clinical implications that would be useful for us as dermatologists